Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR Inhibition

Background/Aims: Radix Angelica Sinensis (danggui in Chinese) is widely used in traditional chinese medicine (TCM). N-butylidenephthalide (BP), a bioactive compound in danggui, is a potential antitumor agent for various cancer types. However, its clinical effect and mechanism in the treatment of gas...

Full description

Bibliographic Details
Main Authors: Kuan-Fu Liao, Tsung-Lang Chiu, Sung-Ying Huang, Teng-Fu Hsieh, Shu-Fang Chang, Jhen-Wei Ruan, Shee-Ping Chen, Cheng-Yoong Pang, Sheng-Chun Chiu
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-08-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:https://www.karger.com/Article/FullText/492641
id doaj-da13dd5117c24658bd176aa2ffe390c3
record_format Article
spelling doaj-da13dd5117c24658bd176aa2ffe390c32020-11-25T02:22:57ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-08-014862231224610.1159/000492641492641Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR InhibitionKuan-Fu LiaoTsung-Lang ChiuSung-Ying HuangTeng-Fu HsiehShu-Fang ChangJhen-Wei RuanShee-Ping ChenCheng-Yoong PangSheng-Chun ChiuBackground/Aims: Radix Angelica Sinensis (danggui in Chinese) is widely used in traditional chinese medicine (TCM). N-butylidenephthalide (BP), a bioactive compound in danggui, is a potential antitumor agent for various cancer types. However, its clinical effect and mechanism in the treatment of gastric cancer remain undetermined. Methods: The in vivo protective effect of danggui in patients with gastric cancer were validated using data from Taiwan’s National Health Insurance Research Database (NHIRD). The genes induced by BP-treatment were analyzed by whole transcriptome RNA sequencing (RNA-seq) and validated by real-time PCR, western blot and siRNA transfection. The effect of BP on AGS cell migration and invasion was evaluated in transwell assays. The antitumor effects of BP were evaluated in vivo in an AGS xenograft animal model. Results: Danggui users were found to have an increased survival rate when compared with danggui nonusers (log-rank test p = 0.002) . The use of danggui highly associated with decreased mortality (the adjusted hazard ratio (HR) of danggui user was 0.72 [95 % CI, 0.57-0.92] (p = 0.009). The in vitro results showed that BP inhibited gastric cancer cell proliferation, and triggered cellular apoptosis depending on the activation of mitochondrial apoptotic pathway. Using RNA-seq analysis we found that REDD1 was the highest transcript induced by BP in gastric cancer cells. BP induce an increase of REDD1 expression that inhibits mTOR signaling, thus inhibiting gastric cancer growth. We used RNA interference to demonstrate that the knock-down of REDD1 attenuated the BP-induced mTORC1 activation and growth inhibition. BP suppressed the growth of AGS xenografts tumor in vivo. Conclusion: Danggui can prolong the survival rate of gastric cancer patients in Taiwan. BP caused gastric cancer cell death through the activation of mitochondria-intrinsic pathway and induced the REDD1 expression leading to mTOR signal pathway inhibition in gastric cancer cells. BP inhibited the in vivo growth of AGS xenograft tumors. These results may provide the basis for a new therapeutic approach toward the treatment of gastric cancer progression.https://www.karger.com/Article/FullText/492641N-butylidenephthalideGastric cancerMTORREDD1Metastasis
collection DOAJ
language English
format Article
sources DOAJ
author Kuan-Fu Liao
Tsung-Lang Chiu
Sung-Ying Huang
Teng-Fu Hsieh
Shu-Fang Chang
Jhen-Wei Ruan
Shee-Ping Chen
Cheng-Yoong Pang
Sheng-Chun Chiu
spellingShingle Kuan-Fu Liao
Tsung-Lang Chiu
Sung-Ying Huang
Teng-Fu Hsieh
Shu-Fang Chang
Jhen-Wei Ruan
Shee-Ping Chen
Cheng-Yoong Pang
Sheng-Chun Chiu
Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR Inhibition
Cellular Physiology and Biochemistry
N-butylidenephthalide
Gastric cancer
MTOR
REDD1
Metastasis
author_facet Kuan-Fu Liao
Tsung-Lang Chiu
Sung-Ying Huang
Teng-Fu Hsieh
Shu-Fang Chang
Jhen-Wei Ruan
Shee-Ping Chen
Cheng-Yoong Pang
Sheng-Chun Chiu
author_sort Kuan-Fu Liao
title Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR Inhibition
title_short Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR Inhibition
title_full Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR Inhibition
title_fullStr Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR Inhibition
title_full_unstemmed Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR Inhibition
title_sort anti-cancer effects of radix angelica sinensis (danggui) and n-butylidenephthalide on gastric cancer: implications for redd1 activation and mtor inhibition
publisher Cell Physiol Biochem Press GmbH & Co KG
series Cellular Physiology and Biochemistry
issn 1015-8987
1421-9778
publishDate 2018-08-01
description Background/Aims: Radix Angelica Sinensis (danggui in Chinese) is widely used in traditional chinese medicine (TCM). N-butylidenephthalide (BP), a bioactive compound in danggui, is a potential antitumor agent for various cancer types. However, its clinical effect and mechanism in the treatment of gastric cancer remain undetermined. Methods: The in vivo protective effect of danggui in patients with gastric cancer were validated using data from Taiwan’s National Health Insurance Research Database (NHIRD). The genes induced by BP-treatment were analyzed by whole transcriptome RNA sequencing (RNA-seq) and validated by real-time PCR, western blot and siRNA transfection. The effect of BP on AGS cell migration and invasion was evaluated in transwell assays. The antitumor effects of BP were evaluated in vivo in an AGS xenograft animal model. Results: Danggui users were found to have an increased survival rate when compared with danggui nonusers (log-rank test p = 0.002) . The use of danggui highly associated with decreased mortality (the adjusted hazard ratio (HR) of danggui user was 0.72 [95 % CI, 0.57-0.92] (p = 0.009). The in vitro results showed that BP inhibited gastric cancer cell proliferation, and triggered cellular apoptosis depending on the activation of mitochondrial apoptotic pathway. Using RNA-seq analysis we found that REDD1 was the highest transcript induced by BP in gastric cancer cells. BP induce an increase of REDD1 expression that inhibits mTOR signaling, thus inhibiting gastric cancer growth. We used RNA interference to demonstrate that the knock-down of REDD1 attenuated the BP-induced mTORC1 activation and growth inhibition. BP suppressed the growth of AGS xenografts tumor in vivo. Conclusion: Danggui can prolong the survival rate of gastric cancer patients in Taiwan. BP caused gastric cancer cell death through the activation of mitochondria-intrinsic pathway and induced the REDD1 expression leading to mTOR signal pathway inhibition in gastric cancer cells. BP inhibited the in vivo growth of AGS xenograft tumors. These results may provide the basis for a new therapeutic approach toward the treatment of gastric cancer progression.
topic N-butylidenephthalide
Gastric cancer
MTOR
REDD1
Metastasis
url https://www.karger.com/Article/FullText/492641
work_keys_str_mv AT kuanfuliao anticancereffectsofradixangelicasinensisdangguiandnbutylidenephthalideongastriccancerimplicationsforredd1activationandmtorinhibition
AT tsunglangchiu anticancereffectsofradixangelicasinensisdangguiandnbutylidenephthalideongastriccancerimplicationsforredd1activationandmtorinhibition
AT sungyinghuang anticancereffectsofradixangelicasinensisdangguiandnbutylidenephthalideongastriccancerimplicationsforredd1activationandmtorinhibition
AT tengfuhsieh anticancereffectsofradixangelicasinensisdangguiandnbutylidenephthalideongastriccancerimplicationsforredd1activationandmtorinhibition
AT shufangchang anticancereffectsofradixangelicasinensisdangguiandnbutylidenephthalideongastriccancerimplicationsforredd1activationandmtorinhibition
AT jhenweiruan anticancereffectsofradixangelicasinensisdangguiandnbutylidenephthalideongastriccancerimplicationsforredd1activationandmtorinhibition
AT sheepingchen anticancereffectsofradixangelicasinensisdangguiandnbutylidenephthalideongastriccancerimplicationsforredd1activationandmtorinhibition
AT chengyoongpang anticancereffectsofradixangelicasinensisdangguiandnbutylidenephthalideongastriccancerimplicationsforredd1activationandmtorinhibition
AT shengchunchiu anticancereffectsofradixangelicasinensisdangguiandnbutylidenephthalideongastriccancerimplicationsforredd1activationandmtorinhibition
_version_ 1724860822667132928